Literature DB >> 21630248

Early viral replication in lymph nodes provides HIV with a means by which to escape NK-cell-mediated control.

Rutger Luteijn1, Gaia Sciaranghella, Jan van Lunzen, Anne Nolting, Anne-Sophie Dugast, Musie S Ghebremichael, Marcus Altfeld, Galit Alter.   

Abstract

Acute HIV infection is marked by dramatic viral replication associated with preferential replication within secondary lymphoid tissues, such as lymph nodes (LNs), that is rapidly but incompletely contained to a viral setpoint. Accumulating evidence supports a role for natural killer (NK) cells in the early control of HIV infection; however, little is known about the location of their antiviral control. Given that HIV replicates profusely in LNs during early infection, we sought to define whether changes occurred in the NK cell infiltrate within these sites during the first year of HIV infection. Surprisingly, NK cell numbers and distribution were unaltered during early HIV infection. LN NK cells expressed decreased inhibitory receptors, were more highly activated, and expressed elevated TRAIL, potentially conferring a superior capacity for NK cells to become activated and control infection. Most noticeably, KIR(+) NK cells were rarely detected in the LN during HIV infection, associated with diminished migratory capacity in the setting of reduced expression of CX3CR1 and CXCR1. Thus, incomplete control of HIV viral replication during early disease may be due to the inefficient recruitment of KIR(+) NK cells to this vulnerable site, providing HIV a niche where it can replicate unabated by early NK-cell-mediated innate pressure.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21630248      PMCID: PMC8943700          DOI: 10.1002/eji.201040886

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  63 in total

1.  2B4 functions as a co-receptor in human NK cell activation.

Authors:  S Sivori; S Parolini; M Falco; E Marcenaro; R Biassoni; C Bottino; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

2.  Lymphoid organs function as major reservoirs for human immunodeficiency virus.

Authors:  G Pantaleo; C Graziosi; L Butini; P A Pizzo; S M Schnittman; D P Kotler; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

3.  Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes.

Authors:  B R Lane; R M Strieter; M J Coffey; D M Markovitz
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Phenotypic and functional characterization of lymphocytes derived from normal and HIV-1-infected human lymph nodes.

Authors:  N Tedla; J Dwyer; P Truskett; D Taub; D Wakefield; A Lloyd
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

5.  Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells.

Authors:  David B Rosen; Wei Cao; Danielle T Avery; Stuart G Tangye; Yong-Jun Liu; J P Houchins; Lewis L Lanier
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

6.  Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection.

Authors:  Emma L Turnbull; MaiLee Wong; Shuyi Wang; Xiping Wei; Nicola A Jones; Karen E Conrod; Diana Aldam; Jo Turner; Pierre Pellegrino; Brandon F Keele; Ian Williams; George M Shaw; Persephone Borrow
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

7.  Programmed death 1: a critical regulator of T-cell function and a strong target for immunotherapies for chronic viral infections.

Authors:  Lydie Trautmann; Elias A Said; Rabih Halwani; Loury Janbazian; Nicolas Chomont; Mohamed El-Far; Gaëlle Breton; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Curr Opin HIV AIDS       Date:  2007-05       Impact factor: 4.283

8.  Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor.

Authors:  Giada Frascaroli; Stefania Varani; Nina Blankenhorn; Robert Pretsch; Michael Bacher; Lin Leng; Richard Bucala; Maria Paola Landini; Thomas Mertens
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

9.  Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells.

Authors:  Magdalena Moutaftsi; Paul Brennan; Stephen A Spector; Zsuzsanna Tabi
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 10.  Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection.

Authors:  G Pantaleo; C Graziosi; J F Demarest; O J Cohen; M Vaccarezza; K Gantt; C Muro-Cacho; A S Fauci
Journal:  Immunol Rev       Date:  1994-08       Impact factor: 12.988

View more
  15 in total

1.  Accumulation of Cytotoxic CD16+ NK Cells in Simian Immunodeficiency Virus-Infected Lymph Nodes Associated with In Situ Differentiation and Functional Anergy.

Authors:  Jamie L Schafer; Haiying Li; Tristan I Evans; Jacob D Estes; R Keith Reeves
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

2.  Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys.

Authors:  Nicolas Huot; Beatrice Jacquelin; Thalia Garcia-Tellez; Philippe Rascle; Mickaël J Ploquin; Yoann Madec; R Keith Reeves; Nathalie Derreudre-Bosquet; Michaela Müller-Trutwin
Journal:  Nat Med       Date:  2017-10-16       Impact factor: 53.440

Review 3.  HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape.

Authors:  Virginia Carroll; Alfredo Garzino-Demo
Journal:  Pathog Dis       Date:  2015-06-29       Impact factor: 3.166

4.  In vivo assessment of natural killer cell responses during chronic feline immunodeficiency virus infection.

Authors:  Rita D Simões; Kristina E Howard; Gregg A Dean
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

5.  Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity.

Authors:  Jonathan Richard; Maxime Veillette; Shilei Ding; Daria Zoubchenok; Nirmin Alsahafi; Mathieu Coutu; Nathalie Brassard; Jongwoo Park; Joel R Courter; Bruno Melillo; Amos B Smith; George M Shaw; Beatrice H Hahn; Joseph Sodroski; Daniel E Kaufmann; Andrés Finzi
Journal:  EBioMedicine       Date:  2015-12-09       Impact factor: 8.143

Review 6.  Role of Natural Killer Cells in HIV-Associated Malignancies.

Authors:  Fabio E Leal; Thomas A Premeaux; Mohamed Abdel-Mohsen; Lishomwa C Ndhlovu
Journal:  Front Immunol       Date:  2017-03-21       Impact factor: 7.561

7.  Changes in Natural Killer cell activation and function during primary HIV-1 Infection.

Authors:  Vivek Naranbhai; Marcus Altfeld; Salim S Abdool Karim; Thumbi Ndung'u; Quarraisha Abdool Karim; William H Carr
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

8.  A novel acute HIV infection staging system based on 4th generation immunoassay.

Authors:  Jintanat Ananworanich; James L K Fletcher; Suteeraporn Pinyakorn; Frits van Griensven; Claire Vandergeeten; Alexandra Schuetz; Tippawan Pankam; Rapee Trichavaroj; Siriwat Akapirat; Nitiya Chomchey; Praphan Phanuphak; Nicolas Chomont; Nelson L Michael; Jerome H Kim; Mark de Souza
Journal:  Retrovirology       Date:  2013-05-29       Impact factor: 4.602

Review 9.  Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence.

Authors:  Scott M Sugden; Mariana G Bego; Tram N Q Pham; Éric A Cohen
Journal:  Viruses       Date:  2016-03-03       Impact factor: 5.048

Review 10.  NK Cells in HIV Disease.

Authors:  Eileen Scully; Galit Alter
Journal:  Curr HIV/AIDS Rep       Date:  2016-04       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.